Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
AssigneeEli Lilly and Company
InventorsPeter Gallagher, Richard Edmund Rathmell, Maria Ann Fagan
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsPeter Gallagher, Richard Edmund Rathmell, Maria Ann Fagan
Estimating the term…
There is provided a heretoaryloxy 3-substituted propanamine compound of formula (I): wherein A is selected from —O— and —S—; X is selected from phenyl optionally substituted with up to 5 substituents selected from halo, C1-C4 alkyl and C1-C4 alkoxy, and thienyl optionally substituted with up to 3 substituents selected from halo and C1-C4 alkyl; Y is selected from benzothienyl, indolyl and benzofuranyl, optionally substituted with up to 5 substituents selected from halo, C1-C4 alkyl, C1-C4 alkoxy, nitro, acetyl and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1-C4 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereof. 1
A compound of formula I:
A compound as claimed in any one of the preceding claims, wherein one of R1 and R2 is H.
A compounds as claimed in any one of the preceding claims, wherein one of R1 and R2 is H and the other is methyl.
A compound as claimed in any one of the preceding claims, wherein
A compound as claimed in any one of the preceding claims, wherein Y is indolyl.
A compound as claimed in any one of the preceding claims, wherein the point of attachment of the group Y to the —O— or —S— atom is attachment at the 7 position.
A compound as claimed in claim 14, wherein Y halo-substituted benzothienyl.
Dependencies are inferred from the claim text.